The challenge is to get these results into clinical practice, to get the drug used by the people who will benefit from it, who will live longer without dialysis, without heart attacks, without strokes, if they take this drug. Novo Nordisk will need to seek regulatory approval for semaglutide to be used to treat those with chronic kidney disease
Wellness Consult $199 Lab Draw $149 Weight Loss Follow-Up $75 EXPLORE OUR WELLNESS MEMBERSHIPS Achieve your goals with ease through our Medical Weight Loss Memberships
For now, AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer have all agreed to sell certain brand-name, non-generic drugs through the platform
It is studied in animal models for its reported effects on the nitric-oxide (NO) system, angiogenic signaling, and connective-tissue repair, and is supplied to qualified laboratories as a lyophilized reference peptide for benchtop research only